16cd3370 8ddc 4dbb 82b3 98e128fb3482 01
Chemical structure diagram of Memantine Hydrochloride showing its molecular framework.*
Memantine Hydrochloride
Product Images NDC 63629-7397
11 FDA label images from Bryant Ranch Prepack · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Memantine Hydrochloride (NDC 63629-7397). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
16cd3370 8ddc 4dbb 82b3 98e128fb3482 02
A line graph comparing mean changes in ADCS-ADL scores from baseline over 28 weeks of treatment for Memantine Hydrochloride versus placebo. The y-axis represents mean change with standard error, ranging from clinical improvement to clinical decline, and the x-axis shows weeks of treatment (0, 4, 12, and 28). Memantine Hydrochloride shows less decline compared to placebo over time.*
16cd3370 8ddc 4dbb 82b3 98e128fb3482 03
A line graph comparing the cumulative percentage of patients on the y-axis against the ADCS-ADL change from baseline on the x-axis. The graph includes two lines representing Placebo and Memantine Hydrochloride, showing the distribution of patient responses over a range of ADCS-ADL changes.*
16cd3370 8ddc 4dbb 82b3 98e128fb3482 04
A line graph comparing the mean change from baseline in SIB (Severe Impairment Battery) score over 28 weeks of treatment between placebo and Memantine Hydrochloride groups. The graph includes error bars and shows two lines: one for placebo and one for Memantine Hydrochloride. The y-axis represents change in SIB score with indicators for clinical improvement and clinical decline, while the x-axis indicates weeks of treatment.*
16cd3370 8ddc 4dbb 82b3 98e128fb3482 05
A cumulative percentage of patients graph comparing Memantine Hydrochloride and placebo, plotting SIB (Severe Impairment Battery) change from baseline on the X-axis against cumulative percentage of patients on the Y-axis. The graph shows two lines, one for placebo and one for Memantine Hydrochloride, indicating patient response distributions.*
16cd3370 8ddc 4dbb 82b3 98e128fb3482 06
A line graph comparing the mean change from baseline in the MA-ADL score over 24 weeks of treatment for two groups: Placebo/Donepezil and Memantine Hydrochloride/Donepezil. The vertical axis represents the mean change score with indicators for clinical improvement and decline, while the horizontal axis shows weeks of treatment. Error bars illustrate variability at each time point.*
16cd3370 8ddc 4dbb 82b3 98e128fb3482 07
A line graph showing the cumulative percentage of patients on the vertical axis plotted against the ADCS-ADL change from baseline on the horizontal axis. Two groups are compared: Placebo/Donepezil represented by a solid square line, and Memantine Hydrochloride/Donepezil represented by an open circle line. The graph illustrates differences in patient response between the two treatment groups over a range of ADCS-ADL changes.*
16cd3370 8ddc 4dbb 82b3 98e128fb3482 08
A line graph showing the mean change from baseline in SIB score over 24 weeks of treatment comparing Memantine Hydrochloride/Donepezil to Placebo/Donepezil. The graph includes error bars indicating SEM and illustrates clinical improvement and decline zones on the y-axis.*
16cd3370 8ddc 4dbb 82b3 98e128fb3482 09
A line graph comparing cumulative percentages of patients versus SIB change from baseline for Placebo/Donepezil and Memantine Hydrochloride/Donepezil groups. The x-axis shows SIB change from baseline, and the y-axis shows cumulative percentage of patients. Two lines represent the treatments, with Memantine Hydrochloride/Donepezil indicated by circles and Placebo/Donepezil by squares.*
16cd3370 8ddc 4dbb 82b3 98e128fb3482 10
Label Image (Lbl636297397)
Memantine Hydrochloride 10mg tablet label packaged by Bryant Ranch Prepack, Burbank, CA. The label indicates a quantity of 30 tablets and includes storage instructions to keep at room temperature (20°-25°C). It compares to Namenda 10mg tablet by Unichem Laboratories Limited. The product is marked Rx Only and shows the NDC 63629-7397.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
